Blackford Analysis

Blackford Analysis is a UK-based healthcare technology company specializing in enterprise AI orchestration platforms for medical imaging and radiology. Founded in 2010 and headquartered in Edinburgh, the company enables hospitals, imaging centers, and radiology groups to deploy and manage multiple FDA/CE-approved AI applications through a single integrated platform. Blackford's solution integrates seamlessly into existing PACS and imaging informatics workflows, supporting 130+ contracted AI applications from 50+ vendor partners across 8 clinical service lines (Body, Breast, Cardiology, MSK, Neurology, Operational, Pediatric, Thoracic). The platform provides regulatory-compliant AI management with enhanced diagnostic confidence, operational efficiency, and ROI measurement. Deployed in over 1,000 hospitals and imaging centers primarily across North America and Australasia. Acquired by Bayer in January 2023.